![]() ![]() ![]() Small cap commentator Doc Holiday talks about: (Interview starts at 1 minute 44 seconds) To put ImmuPharma (IMM) on your Vox Markets watchlist click here and hit the, “Follow” button. Lupuzor™ is their lead compound and a potential treatment for lupus (or Systemic Lupus Erythematosus), a chronic, potentially life-threatening auto-immune disease. ImmuPharma (IMM) is a pharmaceutical development company. Tim McCarthy, Non-executive Chairman of Immupharma (IMM) discusses their invitation from the Mauritian Government to open an additional site to enrol up to 30 Lupus patients. Please do you own research.ĥ79 – Immupharma, Doc on AFPO, SRC, LIFE and Alan Green on RNWH The content of this podcast (or content associated with it) is not intended as investment advice and people featured may hold positions in the companies they talk about. If you find this podcast useful please give it a rating and review on iTunes by clicking here ![]() TO LISTEN TO THE PODCAST CLICK THE PLAY BUTTON BELOW Momentum is eight tenths of the law and for now CloudTag seems flush as birds of a feather flock together. The suggestions that the company are not quiet delivering enough revenue or worse have mislead the markets on a number of points and finally (at best) a poor mans fitbug has the vultures and bears circling, the outcome is one watched with great interest and with all junior companies those detractors (as with speculators) will need to be on point with timing. Clearly CloudTag has the junior markets attention but does it have the attention of the wider markets and users?. Developers are going hammer and tongue to get applications to market on critical mass, those which have high-profile marketing campaigns often do best and those that fill a niche spot in the market snowball into greatness. The caveat to all that is positive across the markets with regard to CloudTag is the concept and idea was created long before the technology advanced and that in fact now the technology is advancing that fast that the window of opportunity is narrowing. Other apps such as Run Keeper, Endmondo sport tracker or Strava are but many apps which flood the markets and whilst some will lead to great things others will wilt and die offering nothing more than a concept that became outdated as the fast pace of tech development proceeds them. The market size of such devices if proven is incredible, we have seen lesser important apps such as Angry Birds, Snapchat, Clash of Clans, or PokemonGo show just what sort of value can come from viral supremacy. The company has a number of high-profile affiliates and presenters demonstrating just how good this wearable device when configured with the app really is, they have growing relationships in a huge yet diverse market and whilst shares have risen dramatically the highly motivated investment community demands even more, the complexity of securing patents developing industry relationships to validate technology whilst growing the public face of the CloudTag brand is not an easy one however the recent spike of interest is the best PR by far. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |